Trademark applications and grants for Amgen Inc. Amgen Inc has 726 trademark applications. The latest application filed is for "LATTICE LEADING AWARENESS TO ACTION THROUGH IMPLEMENTATION OF CARDIOMETABOLIC EFFORTS"
Patent Application | Date |
---|---|
RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF 20220307022 - 17/615520 DAS; Amrita ;   et al. | 2022-09-29 |
Purification Method for Bispecific antigen-binding Polypeptides with Enhanced Protein L Capture Dynamic Binding Capacity 20220306741 - 17/641736 Sharma; Ashish ;   et al. | 2022-09-29 |
CYCLOBUTYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS 20220306604 - 17/633151 MILGRAM; Benjamin C ;   et al. | 2022-09-29 |
SYRINGE ADAPTER AND GUIDE FOR FILLING AN ON-BODY INJECTOR 20220305203 - 17/840253 Stonecipher; Brian | 2022-09-29 |
INHIBITIONS OF SIRP-GAMMA FOR CANCER TREATMENT 20220305081 - 17/618922 HU; Ruozhen ;   et al. | 2022-09-29 |
NCAGE Code | 0JVZ6 | AMGEN INC. |
NCAGE Code | 0P4V3 | AMGEN INC. |
NCAGE Code | 4SW25 | AMGEN INC. |
CAGE Code | 0JVZ6 | AMGEN INC. |
CAGE Code | 0P4V3 | AMGEN, INC. |
CAGE Code | 4SW25 | AMGEN INC. |
S.A.M. Registration | 0JVZ6 [39976196] | AMGEN INC. |
SEC | 0000318154 | AMGEN INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.